My guess is that "788" (NM) will address the EGFR mutation, as Aria was hot on the trail of EGFR when they developed "113", but missed. That would be a huge market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.